I am a PhD candidate in the Public Health (Epidemiology) program at the University of Montreal and affiliated CHUM research centre in Montreal, Canada. My research focuses on the role of social and geographic factors in shaping risk of HCV and drug-related harms among people who inject drugs.

Jack is an infectious disease mathematical modeller based in Population Health Sciences at the University of Bristol. He works on mathematical models of hepatitis C virus (HCV) and HIV transmission among high-risk populations, including people who inject drugs

Post-doc research assistant at the University of Applied Sciences of Southern Switzerland. PhD in Communication Sciences (specialization in Discourse studies and Argumentation) from the Università della Svizzera italiana (Switzerland). Her research interests are in the areas of interaction in all kinds of contexts, ethnography of communication, argumentation and discourse analysis.

Brooke Severe is a Masters of Public Health student at Yale School of Public Health, graduating in May 2019. She became interested in hepatitis C research at an AIDS Education Month conference and has interned for the State of Maryland Department of Health, Center for Viral Hepatitis.

Sarah Larney is a Senior Research Fellow at the National Drug and Alcohol Research Centre, UNSW Australia. Her research focuses on opioid and injecting drug use and related harms including hepatitis C, skin and soft tissue infections and exposure to law enforcement systems.

Dr Rosenthal is an infectious disease physician at the Institute of Human Virology at the University of Maryland School of Medicine, and is co-director of the DC Partnership for HIV/AIDS Progress Hepatitis Clinical Research Program. Her research and clinical interests are the intersection of infections and substance use disorder.